In acetaminophen (Tylenol) overdose, what prothrombin time and international normalized ratio (INR) thresholds are clinically significant, and what is the recommended duration of N‑acetylcysteine (NAC) therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Acetaminophen Overdose: PT/INR Significance and NAC Duration

PT/INR Thresholds in Acetaminophen Toxicity

In acetaminophen overdose, PT/INR elevation indicates hepatic synthetic dysfunction and is a marker of severe hepatotoxicity, but specific thresholds are not used for treatment decisions—instead, any elevation of INR alongside hepatotoxicity (AST/ALT >1,000 IU/L) signals the need for continued NAC therapy. 1

Key Laboratory Markers to Monitor:

  • Hepatotoxicity definition: Any increase in AST/ALT concentrations 1
  • Severe hepatotoxicity: AST >1,000 IU/L 1
  • Hepatic failure: Hepatotoxicity with hepatic encephalopathy 1
  • Essential labs: AST, ALT, bilirubin, INR, creatinine, BUN, blood glucose, and electrolytes 2

Critical caveat: Recent research demonstrates that acetylcysteine itself can artificially elevate INR in vitro, with every mmol/L (163 mg/L) of NAC increasing INR by 0.039, and this effect shows large interindividual variability 3. This means INR elevation during NAC treatment may not purely reflect hepatic injury, though this should not delay treatment decisions.

NAC Treatment Duration

The standard NAC regimen is 300 mg/kg administered intravenously over 21 hours as three separate doses (loading dose followed by two maintenance doses), but treatment should be extended beyond 21 hours if acetaminophen remains detectable, transaminases are rising, or INR is elevated. 2

Standard 21-Hour Protocol (FDA-Approved):

  • Loading dose: 150 mg/kg over 1 hour
  • Second dose: 50 mg/kg over 4 hours
  • Third dose: 100 mg/kg over 16 hours
  • Total: 300 mg/kg over 21 hours 2

When to Continue NAC Beyond 21 Hours:

Continue NAC at 100 mg/kg over 16 hours (repeating the third dose) if ANY of the following are present at 21 hours:

  • Detectable serum acetaminophen (>10 mg/L) 4, 5
  • AST/ALT still rising or elevated 4, 5
  • INR elevated or worsening 4
  • Clinical evidence of hepatotoxicity 1

Early Stopping Criteria (for selected low-risk patients):

NAC can be safely stopped at 12 hours in very low-risk patients who meet ALL of the following criteria:

  • Normal ALT and creatinine at presentation and at 12 hours
  • Acetaminophen <20 mg/L at 12 hours
  • Single or staggered overdose (not repeated supratherapeutic ingestion) 5

This approach was validated in the NACSTOP trial, where no patients developed hepatic injury when these criteria were met 5.

Treatment Timing and Efficacy

The critical window for NAC efficacy is 0-8 hours post-ingestion, with progressive decline in effectiveness after 8 hours, though NAC should never be withheld even if presentation is delayed beyond 24 hours. 1, 2

Time-Dependent Outcomes:

  • <8 hours: Severe hepatotoxicity rate 2.9% 1
  • <10 hours: Severe hepatotoxicity rate 6.1%, no mortality 1
  • >10 hours: Severe hepatotoxicity rate 26.4% 1
  • 16-24 hours: Severe hepatotoxicity rate up to 62% in high-risk patients 1

Special Populations Requiring Extended Treatment

Administer NAC immediately and continue for full 21 hours (or longer) in these situations:

  • Hepatic failure: Level B recommendation to treat with NAC regardless of timing 1
  • Existing hepatotoxicity: Level C recommendation for any hepatotoxicity with suspected acetaminophen overdose 1
  • Repeated supratherapeutic ingestions: Cannot use Rumack-Matthew nomogram; treat based on clinical presentation and labs 1, 2
  • Unknown time of ingestion: Start NAC immediately, obtain levels to guide continuation 2
  • Extended-release formulations: May require second acetaminophen level at 8-10 hours 2

Common Pitfalls to Avoid

  1. Don't wait for acetaminophen levels if >8 hours post-ingestion or clinical toxicity present—start NAC immediately 2

  2. Don't stop NAC at 21 hours automatically—check acetaminophen level, transaminases, and INR first 4, 5

  3. Don't rely solely on INR as a marker of hepatotoxicity during NAC treatment—NAC itself can elevate INR artificially 3

  4. Don't use the Rumack-Matthew nomogram for repeated supratherapeutic ingestions—these patients require individualized assessment based on cumulative dose and laboratory findings 1, 2

  5. Don't assume normal transaminases in the ED exclude toxicity—hepatotoxicity can develop over subsequent hours 1

References

Related Questions

What is the recommended N‑acetylcysteine (NAC) dosing regimen for a 50‑kg patient with acetaminophen overdose?
When should N‑acetylcysteine be stopped in a patient with acetaminophen (Tylenol) overdose?
What is the recommended duration of N‑acetylcysteine therapy?
What is the recommended N‑acetylcysteine (NAC) infusion regimen for acetaminophen (paracetamol) overdose?
What is the dose of N-Acetylcysteine (NAC)?
In a patient with active gastritis who is taking a selective serotonin reuptake inhibitor (SSRI), should the SSRI be continued and what management steps are recommended?
In a patient with new‑onset rapid atrial fibrillation and hypotension, should amiodarone or digoxin be used?
How should cefoperazone/sulbactam be dosed in a patient with acute kidney injury?
In a 60-year-old woman on day 5 of antibiotic therapy for a urinary tract infection with persistent dysuria, urgency, and a new low-grade fever, what is the appropriate next step in management?
In an older adult with significant visual loss experiencing vivid visual hallucinations consistent with Charles Bonnet syndrome, what psychiatric manifestations may occur and how should they be evaluated and managed?
Is it safe to apply heat therapy for lateral knee tendinopathy after the acute inflammatory phase?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.